hotspot -WSS

hotspot

author：leisure time 2025-09-30 15:17:00 - browse：4845

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： NIH trials fail to test meaningful long Covid therapies, experts say

WSS

Why failed clinical trials don’t always spell doom for a new drug

How many hemophilia patients actually want gene therapy?

How to use technology to prevent future drug shortages

Amid AI frenzy, a top HHS official's quest to create safeguards

Wegovy trial has doctors encouraged over new possibilities

RaDonda Vaught links Vanderbilt hospital issues to patient death

focus

hotspot

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

John Green on his newest strategy for fighting tuberculosis

In age of alternative facts, a scholarly course on calling out crap

The best solution to the drug shortages problem

How one medical school became remarkably diverse

FDA panel issues narrow recommendation for Covid vaccine booster doses

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In same hospitals, Black patients receive fewer opioids than white patients

23andMe had bad news about my health. I wish a person had delivered it

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

explore

Wegovy trial has doctors encouraged over new possibilities

Wegovy’s successful heart trial raises vital question about weight loss

Methadone doses haven’t kept up in the age of fentanyl

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Police still searching for prisoner who escaped from NYC hospital

Naloxone nonprofit donates 200,000 doses after FDA approval

hotspot

Wikipedia

knowledge

focus